ND1 ESTIMATING COST-EFFECTIVENESS OF DRUGS THAT DELAY DISABILITY PROGRESSION IN MULTIPLE SCLEROSIS USING NET BENEFIT REGRESSION MODEL METHODS
May 1, 2004, 00:00
10.1016/S1098-3015(10)62118-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)62118-3/fulltext
Title :
ND1 ESTIMATING COST-EFFECTIVENESS OF DRUGS THAT DELAY DISABILITY PROGRESSION IN MULTIPLE SCLEROSIS USING NET BENEFIT REGRESSION MODEL METHODS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62118-3&doi=10.1016/S1098-3015(10)62118-3
First page :
Section Title :
Open access? :
No
Section Order :
56